Market revenue in 2023 | USD 1,161.6 million |
Market revenue in 2030 | USD 2,336.2 million |
Growth rate | 10.5% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data covered | 2021 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Due to the COVID-19 pandemic, vaccine developers entered into strategic agreements with contract development and manufacturing service providers to meet the urgent global demand for mRNAbased vaccines, which led to significant growth in the outsourcing industry.
Moreover, manufacturing mRNA therapeutics is complex, cost-intensive, and requires skilled professionals. Thus, several small- to medium-sized companies rely on CDMO to produce mRNA-synthesized products to innovate new mRNA therapeutics.
For instance, in February 2022, Moderna, Inc. announced expansion of its commercial network in Denmark, Belgium, Norway, the Netherlands, Poland, and Sweden to support the delivery of mRNA vaccines & therapeutics locally.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account